Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Origin of the Isomer Stability of Polymethylated DOTA Chelates Complexed with Ln ³⁺ ions.

Autor: Lee YS; Dr. Yong-Sok Lee, Dr. Zhongyu Mou Center for Molecular Modeling, Office of Intramural Research, Center for Information Technology, National Institutes of Health, Bethesda, MD 20892, United States.; Present address: Bioinformatics and Computational Bioscience Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, United States., Mou Z; Dr. Yong-Sok Lee, Dr. Zhongyu Mou Center for Molecular Modeling, Office of Intramural Research, Center for Information Technology, National Institutes of Health, Bethesda, MD 20892, United States.; Present address: Intramural Research Program, National Library of Medicine, National Institutes of Health, Bethesda, MD 20892, United States., Opina ACL; Dr. Ana Christina L. Opina, Dr. Olga Vasalatiy Chemistry and Synthesis Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Rockville, MD 20850, United States., Vasalatiy O; Dr. Ana Christina L. Opina, Dr. Olga Vasalatiy Chemistry and Synthesis Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Rockville, MD 20850, United States.

Publikováno v: European journal of inorganic chemistry [Eur J Inorg Chem] 2021 Mar 02; Vol. 2021 (15), pp. 1428-1440.

Immuno-PET Imaging of the Programmed Cell Death-1 Ligand (PD-L1) Using a Zirconium-89 Labeled Therapeutic Antibody, Avelumab.

Autor: Jagoda EM; 1 Molecular Imaging Program, National Cancer Institute, Bethesda, MD, USA., Vasalatiy O; 2 Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Rockville, MD, USA., Basuli F; 2 Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Rockville, MD, USA., Opina ACL; 2 Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Rockville, MD, USA., Williams MR; 1 Molecular Imaging Program, National Cancer Institute, Bethesda, MD, USA., Wong K; 1 Molecular Imaging Program, National Cancer Institute, Bethesda, MD, USA., Lane KC; 2 Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Rockville, MD, USA., Adler S; 1 Molecular Imaging Program, National Cancer Institute, Bethesda, MD, USA., Ton AT; 1 Molecular Imaging Program, National Cancer Institute, Bethesda, MD, USA., Szajek LP; 3 PET Department, Clinical Center, NIH, Bethesda, MD, USA., Xu B; 2 Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Rockville, MD, USA., Butcher D; 4 Pathology & Histotechnology Lab Frederick National Laboratory for Cancer Research, NCI, Frederick, MD, USA., Edmondson EF; 4 Pathology & Histotechnology Lab Frederick National Laboratory for Cancer Research, NCI, Frederick, MD, USA., Swenson RE; 2 Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Rockville, MD, USA., Greiner J; 5 Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, MD, USA., Gulley J; 6 Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, MD, USA.; 7 Clinical Research Directorate/CMRP, Leidos Biomedical Research Inc. (formerly SAIC-Frederick, Inc.), Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Eary J; 8 Cancer Imaging Program, National Cancer Institute, Bethesda, MD, USA., Choyke PL; 1 Molecular Imaging Program, National Cancer Institute, Bethesda, MD, USA.

Publikováno v: Molecular imaging [Mol Imaging] 2019 Jan-Dec; Vol. 18, pp. 1536012119829986.